Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $8.77 in the prior trading day, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) closed at $8.54, down -2.62%. In other words, the price has decreased by -$2.62 from its previous closing price. On the day, 1.6 million shares were traded. AUPH stock price reached its highest trading level at $8.96 during the session, while it also had its lowest trading level at $8.52.
Ratios:
Our goal is to gain a better understanding of AUPH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.40. For the most recent quarter (mrq), Quick Ratio is recorded 5.11 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.19.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 09 ’24 when TANG KEVIN bought 500,000 shares for $9.09 per share. The transaction valued at 4,545,000 led to the insider holds 8,429,500 shares of the business.
TANG KEVIN bought 400,000 shares of AUPH for $3,604,000 on Dec 06 ’24. The Director now owns 7,929,500 shares after completing the transaction at $9.01 per share. On Dec 05 ’24, another insider, TANG KEVIN, who serves as the Director of the company, bought 300,000 shares for $8.91 each. As a result, the insider paid 2,673,000 and bolstered with 7,529,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUPH now has a Market Capitalization of 1222748672 and an Enterprise Value of 962366976. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.40 while its Price-to-Book (P/B) ratio in mrq is 3.15. Its current Enterprise Value per Revenue stands at 4.367 whereas that against EBITDA is 1944.176.
Stock Price History:
Over the past 52 weeks, AUPH has reached a high of $10.67, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is 0.10%, while the 200-Day Moving Average is calculated to be 31.06%.
Shares Statistics:
The stock has traded on average 1.26M shares per day over the past 3-months and 1116620 shares per day over the last 10 days, according to various share statistics. A total of 143.11M shares are outstanding, with a floating share count of 128.78M. Insiders hold about 10.06% of the company’s shares, while institutions hold 39.48% stake in the company. Shares short for AUPH as of 1734048000 were 5529334 with a Short Ratio of 4.39, compared to 1731628800 on 6879228. Therefore, it implies a Short% of Shares Outstanding of 5529334 and a Short% of Float of 3.88.
